Your browser doesn't support javascript.
ABO blood groups and the risk of SARS-CoV-2 infection.
Bullerdiek, Jörn; Reisinger, Emil; Rommel, Birgit; Dotzauer, Andreas.
  • Bullerdiek J; Institute for Medical Genetics, University of Rostock, University Medicine, Ernst-Heydemann-Strasse 8, 18057, Rostock, Germany. joern.bullerdiek@med.uni-rostock.de.
  • Reisinger E; Human Genetics, University of Bremen, Leobener Strasse 2, 28359, Bremen, Germany. joern.bullerdiek@med.uni-rostock.de.
  • Rommel B; Department of Tropical Medicine and Infectious Diseases, Ernst-Heydemann-Strasse 6, 18055, Rostock, Germany.
  • Dotzauer A; Human Genetics, University of Bremen, Leobener Strasse 2, 28359, Bremen, Germany.
Protoplasma ; 259(6): 1381-1395, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-2059870
ABSTRACT
There is no doubt that genetic factors of the host play a role in susceptibility to infectious diseases. An association between ABO blood groups and SARS-CoV-2 infection as well as the severity of COVID-19 has been suggested relatively early during the pandemic and gained enormously high public interest. It was postulated that blood group A predisposes to a higher risk of infection as well as to a much higher risk of severe respiratory disease and that people with blood group O are less frequently and less severely affected by the disease. However, as to the severity of COVID-19, a thorough summary of the existing literature does not support these assumptions in general. Accordingly, at this time, there is no reason to suppose that knowledge of a patient's ABO phenotype should directly influence therapeutical decisions in any way. On the other hand, there are many data available supporting an association between the ABO blood groups and the risk of contracting SARS-CoV-2. To explain this association, several interactions between the virus and the host cell membrane have been proposed which will be discussed here.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Protoplasma Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: S00709-022-01754-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Protoplasma Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: S00709-022-01754-1